CHMP PROM minutes for the meeting on 17 March 2025

Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 24 September 2025

Herbal medicinal product: Combination: Species pectorales, F: Assessment finalised

Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains

First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, European Medicines Agency, Amsterdam, the Netherlands, 5 November 2025

1st EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, European Medicines Agency, Amsterdam, the Netherlands, 5 November 2025

HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)

Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Jubbonti, denosumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 5, Status: Authorised